WebPage 1/7 Safety Data Sheet acc. to OSHA HCS Printing date 09/26/2024 Revision date 09/26/2024 53.1.21 1 Identification · Product identifier · Trade name:INCB 3284 (dimesylate) · Article number:11963 · CAS Number: 887401-93-6 · Application of the substance / the mixture This product is for research use - Not for human or veterinary diagnostic or … WebINCB-3284: Code : English : View: View: BENZAMIDE, N-(2-(((3R)-1-(TRANS-4-HYDROXY-4-(6-METHOXY-3-PYRIDINYL)CYCLOHEXYL)-3-PYRROLIDINYL)AMINO)-2-OXOETHYL)-3 …
INCB-3284 Definition Law Insider
WebHistorical and Revision Notes. Based on section 52(d) of title 11, U.S.C., 1940 ed., Bankruptcy (May 27, 1926, ch. 406, § 11d, 44 Stat. 665; June 22, 1938, ch. 575, § 1, 52 … WebAn Act relative to nurse licensure compact in Massachusetts. By Ms. Khan of Newton, a petition (accompanied by bill, House, No. 1284) of Kay Khan, Colleen M. Garry and Joseph … minerals analysis
INCB 3284 dimesylate, Tocris Bioscience Fisher Scientific
Web93284, Under Implantable, Insertable, and Wearable Cardiac Device Evaluations. The Current Procedural Terminology (CPT ®) code 93284 as maintained by American Medical … WebINCB 3284 dimesylate is a potent, selective hCCR2 antagonist. Exhibits potent antagonism against monocyte chemoattractant molecule binding to hCCR2 and chemotaxis activity (IC 50 values are 3.7 and 4.7 nM respectively). Also displays weak hERG activity; inhibits the hERG potassium current (IC 50 = 84 μ M). Orally bioavailable. WebIn Vitro INCB 3284 dimesylate is a pentent, selective and orally bioavailable human CCR2 antagonist, inhibiting monocyte chemoattractant protein-1 binding to hCCR2, with an IC50 of 3.7 nM. INCB 3284 also causes an IC50 of 4.7 nM in antagonism of chemotaxis activity, an IC50 of 84 μM in inhibition of the hERG potassium current. However, INCB ... moses fading glory